The development of potent aldose reductase inhibitors as therapeutic agents for diabetic complications is highly desirable. The inhibitory action of 54 hydantoin derivatives consisting of 25 hydantoins, 21 2-thiohydantoins and 8 2-alkylthiohydantoins was therefore tested on rat and bovine lens aldose reductases in vitro. 1-(Phenylsulfonyl)-hydantoin (18) and its derivatives, 1-[(substituted phenyl)sulfonyl]hydantoins, were found to be potent inhibitors of the enzymes. 1-[(p-Bromophenyl)sulfonyl]hydantoin (49) was the most potent among them. It inhibited purified rat and bovine lens aldose reductases by 50% at 7×10−7m and 3.7×10−7m, respectively. Inhibition of rat and bovine lens aldose reductases by this compound (49) was due to its non-ionized form, but not the ionized form, and was of a non-competitive type with respect to dl-glyceraldehyde as a substrate. © 1982, The Pharmaceutical Society of Japan. All rights reserved.
CITATION STYLE
Inagaki, K., Miwa, I., Okuda, J., & Yashiro, T. (1982). Inhibition of Aldose Reductases from Rat and Bovine Lenses by Hydantoin Derivatives. Chemical and Pharmaceutical Bulletin, 30(9), 3244–3254. https://doi.org/10.1248/cpb.30.3244
Mendeley helps you to discover research relevant for your work.